| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 1.33e-07 | 43 | 111 | 6 | GO:0030280 | |
| GeneOntologyMolecularFunction | microtubule minus-end binding | 7.25e-05 | 15 | 111 | 3 | GO:0051011 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KRT2 MYH2 MYH3 OFD1 CEP290 ARFGEF2 ARFGEF1 TUBGCP2 JMY NEFH SYNE2 CDK5RAP2 MACF1 PLEKHH2 MYO15A KIF13A | 3.73e-04 | 1099 | 111 | 16 | GO:0008092 |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 5.07e-12 | 99 | 110 | 11 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 5.68e-12 | 100 | 110 | 11 | GO:0045103 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 7.61e-12 | 75 | 110 | 10 | GO:0045109 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KRT1 KRT2 KRT3 MYH3 EPPK1 SWAP70 DSP ARFGEF1 TUBGCP2 JMY KRT80 NEFH KRT39 KRT76 KRT75 CDK5RAP2 PLEKHH2 MYO15A | 2.99e-06 | 957 | 110 | 18 | GO:0097435 |
| GeneOntologyBiologicalProcess | keratinization | 7.13e-06 | 87 | 110 | 6 | GO:0031424 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 6.97e-05 | 189 | 110 | 7 | GO:0030216 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRT1 KRT2 KRT3 EPPK1 DSP KRT80 NEFH KRT39 KRT76 KRT75 SYNE2 SMARCA2 MACF1 | 1.32e-09 | 263 | 110 | 13 | GO:0045111 |
| GeneOntologyCellularComponent | intermediate filament | 3.23e-08 | 227 | 110 | 11 | GO:0005882 | |
| GeneOntologyCellularComponent | keratin filament | 8.02e-07 | 97 | 110 | 7 | GO:0045095 | |
| GeneOntologyCellularComponent | supramolecular fiber | KRT1 KRT2 KRT3 MYH2 MYH3 EPPK1 DSP INPP5D ARFGEF2 TUBGCP2 KRT80 NEFH KRT39 KRT76 KRT75 SYNE2 BYSL CDK5RAP2 MACF1 KIF13A | 3.09e-06 | 1179 | 110 | 20 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT1 KRT2 KRT3 MYH2 MYH3 EPPK1 DSP INPP5D ARFGEF2 TUBGCP2 KRT80 NEFH KRT39 KRT76 KRT75 SYNE2 BYSL CDK5RAP2 MACF1 KIF13A | 3.42e-06 | 1187 | 110 | 20 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT1 KRT2 KRT3 EPPK1 DSP INPP5D ARFGEF2 TUBGCP2 KRT80 NEFH KRT39 KRT76 KRT75 BYSL CDK5RAP2 MACF1 KIF13A | 4.54e-06 | 899 | 110 | 17 | GO:0099513 |
| GeneOntologyCellularComponent | GBAF complex | 4.95e-05 | 14 | 110 | 3 | GO:0140288 | |
| GeneOntologyCellularComponent | cornified envelope | 4.82e-04 | 69 | 110 | 4 | GO:0001533 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 5.19e-04 | 30 | 110 | 3 | GO:0016514 | |
| MousePheno | increased circulating LDL cholesterol level | 3.27e-08 | 80 | 87 | 8 | MP:0000182 | |
| MousePheno | abnormal circulating LDL cholesterol level | 7.70e-06 | 163 | 87 | 8 | MP:0000181 | |
| MousePheno | abnormal circulating non-HDL cholesterol level | 1.59e-05 | 180 | 87 | 8 | MP:0020151 | |
| MousePheno | increased circulating HDL cholesterol level | CT45A6 CT45A1 CT45A10 PRR5 CT45A2 CT45A7 CT45A9 CT45A3 ATP11C | 1.67e-05 | 238 | 87 | 9 | MP:0001556 |
| MousePheno | hyperpigmentation | 2.56e-05 | 28 | 87 | 4 | MP:0001188 | |
| MousePheno | increased foot pad pigmentation | 1.23e-04 | 16 | 87 | 3 | MP:0000575 | |
| MousePheno | increased foot pigmentation | 1.23e-04 | 16 | 87 | 3 | MP:0030051 | |
| MousePheno | increased circulating cholesterol level | CT45A6 CT45A1 CT45A10 PRR5 CT45A2 CT45A7 DARS2 CT45A9 RSBN1 CT45A3 ATP11C | 1.35e-04 | 463 | 87 | 11 | MP:0005178 |
| MousePheno | acanthosis | 1.44e-04 | 43 | 87 | 4 | MP:0001874 | |
| MousePheno | epidermis stratum spinosum hyperplasia | 1.72e-04 | 45 | 87 | 4 | MP:0009611 | |
| MousePheno | increased cholesterol level | CT45A6 CT45A1 CT45A10 PRR5 CT45A2 CT45A7 DARS2 CT45A9 RSBN1 CT45A3 ATP11C | 2.73e-04 | 502 | 87 | 11 | MP:0003982 |
| MousePheno | increased sterol level | CT45A6 CT45A1 CT45A10 PRR5 CT45A2 CT45A7 DARS2 CT45A9 RSBN1 CT45A3 ATP11C | 2.87e-04 | 505 | 87 | 11 | MP:0012226 |
| Domain | INT_SG_DDX_CT_C | 3.41e-10 | 8 | 109 | 5 | PF15300 | |
| Domain | INT_SG_DDX_CT_C | 3.41e-10 | 8 | 109 | 5 | IPR029307 | |
| Domain | Keratin_II | 7.20e-09 | 26 | 109 | 6 | IPR003054 | |
| Domain | Filament | 8.14e-09 | 71 | 109 | 8 | SM01391 | |
| Domain | IF | 9.11e-09 | 72 | 109 | 8 | PS00226 | |
| Domain | Filament | 1.02e-08 | 73 | 109 | 8 | PF00038 | |
| Domain | IF | 1.41e-08 | 76 | 109 | 8 | IPR001664 | |
| Domain | Intermediate_filament_CS | 8.02e-08 | 63 | 109 | 7 | IPR018039 | |
| Domain | Keratin_2_head | 2.40e-07 | 24 | 109 | 5 | IPR032444 | |
| Domain | Keratin_2_head | 2.40e-07 | 24 | 109 | 5 | PF16208 | |
| Domain | - | 3.82e-06 | 6 | 109 | 3 | 3.90.1290.10 | |
| Domain | Plectin_repeat | 6.65e-06 | 7 | 109 | 3 | IPR001101 | |
| Domain | Plectin | 6.65e-06 | 7 | 109 | 3 | PF00681 | |
| Domain | PLEC | 6.65e-06 | 7 | 109 | 3 | SM00250 | |
| Domain | GSCR1_dom | 3.37e-05 | 2 | 109 | 2 | IPR015671 | |
| Domain | GLTSCR1 | 3.37e-05 | 2 | 109 | 2 | PF15249 | |
| Domain | RmlC_Cupin | 1.02e-04 | 16 | 109 | 3 | IPR011051 | |
| Domain | Keratin_I | 1.24e-04 | 44 | 109 | 4 | IPR002957 | |
| Domain | DUF1981 | 2.01e-04 | 4 | 109 | 2 | PF09324 | |
| Domain | Sec7_N | 2.01e-04 | 4 | 109 | 2 | IPR032691 | |
| Domain | DUF4200 | 2.01e-04 | 4 | 109 | 2 | PF13863 | |
| Domain | Sec7_N | 2.01e-04 | 4 | 109 | 2 | PF12783 | |
| Domain | DCB_dom | 2.01e-04 | 4 | 109 | 2 | IPR032629 | |
| Domain | DUF4200 | 2.01e-04 | 4 | 109 | 2 | IPR025252 | |
| Domain | DCB | 2.01e-04 | 4 | 109 | 2 | PF16213 | |
| Domain | Sec7_C | 2.01e-04 | 4 | 109 | 2 | IPR015403 | |
| Domain | tRNA-bd_arm | 3.58e-04 | 24 | 109 | 3 | IPR010978 | |
| Domain | DUF3694 | 4.99e-04 | 6 | 109 | 2 | PF12473 | |
| Domain | Kinesin-like | 4.99e-04 | 6 | 109 | 2 | IPR022164 | |
| Domain | Spectrin_repeat | 6.33e-04 | 29 | 109 | 3 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 8.48e-04 | 32 | 109 | 3 | IPR018159 | |
| Domain | SPEC | 8.48e-04 | 32 | 109 | 3 | SM00150 | |
| Domain | MYTH4 | 1.18e-03 | 9 | 109 | 2 | PS51016 | |
| Domain | MyTH4_dom | 1.18e-03 | 9 | 109 | 2 | IPR000857 | |
| Domain | MyTH4 | 1.18e-03 | 9 | 109 | 2 | PF00784 | |
| Domain | MyTH4 | 1.18e-03 | 9 | 109 | 2 | SM00139 | |
| Domain | IQ | 1.29e-03 | 81 | 109 | 4 | SM00015 | |
| Domain | Myosin_head_motor_dom | 1.41e-03 | 38 | 109 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.41e-03 | 38 | 109 | 3 | PS51456 | |
| Domain | Myosin_head | 1.41e-03 | 38 | 109 | 3 | PF00063 | |
| Domain | MYSc | 1.41e-03 | 38 | 109 | 3 | SM00242 | |
| Domain | IQ_motif_EF-hand-BS | 1.91e-03 | 90 | 109 | 4 | IPR000048 | |
| Domain | GrpE_coiled_coil | 2.14e-03 | 12 | 109 | 2 | IPR013805 | |
| Domain | IQ | 2.15e-03 | 93 | 109 | 4 | PS50096 | |
| Domain | - | 2.15e-03 | 93 | 109 | 4 | 1.10.533.10 | |
| Domain | DEATH-like_dom | 2.70e-03 | 99 | 109 | 4 | IPR011029 | |
| Domain | Myosin_N | 3.37e-03 | 15 | 109 | 2 | PF02736 | |
| Domain | - | 3.37e-03 | 15 | 109 | 2 | 1.10.1000.11 | |
| Domain | Sec7 | 3.37e-03 | 15 | 109 | 2 | PF01369 | |
| Domain | Myosin_N | 3.37e-03 | 15 | 109 | 2 | IPR004009 | |
| Domain | Sec7_alpha_orthog | 3.37e-03 | 15 | 109 | 2 | IPR023394 | |
| Domain | Sec7 | 3.84e-03 | 16 | 109 | 2 | SM00222 | |
| Domain | SEC7 | 3.84e-03 | 16 | 109 | 2 | PS50190 | |
| Domain | Sec7_dom | 3.84e-03 | 16 | 109 | 2 | IPR000904 | |
| Domain | Myosin_tail_1 | 4.86e-03 | 18 | 109 | 2 | PF01576 | |
| Domain | Myosin_tail | 4.86e-03 | 18 | 109 | 2 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 5.41e-03 | 19 | 109 | 2 | IPR027401 | |
| Domain | - | 5.41e-03 | 19 | 109 | 2 | 4.10.270.10 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 4.95e-07 | 87 | 78 | 7 | MM15351 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 5.42e-07 | 129 | 78 | 8 | M27649 | |
| Pathway | REACTOME_KERATINIZATION | 2.14e-05 | 153 | 78 | 7 | MM15343 | |
| Pathway | REACTOME_KERATINIZATION | 2.58e-05 | 217 | 78 | 8 | M27640 | |
| Pubmed | Identification of cancer/testis-antigen genes by massively parallel signature sequencing. | CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A8 CT45A3 CT45A5 | 1.56e-19 | 15 | 114 | 9 | 15905330 |
| Pubmed | 1.60e-09 | 63 | 114 | 7 | 16831889 | ||
| Pubmed | 3.44e-08 | 57 | 114 | 6 | 31862882 | ||
| Pubmed | MYH3 CT45A6 CT45A1 OFD1 CT45A10 CT45A2 CNTLN PRAMEF18 CT45A7 CT45A9 IQCA1 CT45A3 GPAT2 | 3.50e-07 | 674 | 114 | 13 | 37196079 | |
| Pubmed | ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1. | 2.06e-06 | 113 | 114 | 6 | 34474245 | |
| Pubmed | 2.84e-06 | 9 | 114 | 3 | 15737194 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | MYD88 CT45A6 CT45A1 CT45A10 CT45A2 PRAMEF18 CT45A7 DARS2 ARL4D CT45A9 KRT76 CT45A3 VANGL1 CDK5RAP2 MYO15A PLXNA2 | 3.06e-06 | 1242 | 114 | 16 | 30973865 |
| Pubmed | 4.65e-06 | 130 | 114 | 6 | 12421765 | ||
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | 8.70e-06 | 84 | 114 | 5 | 29563501 | |
| Pubmed | 9.58e-06 | 13 | 114 | 3 | 8999895 | ||
| Pubmed | SHIP prevents lipopolysaccharide from triggering an antiviral response in mice. | 1.07e-05 | 2 | 114 | 2 | 19139077 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 23918382 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 11531804 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 17360629 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 10716990 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 18203920 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 10212200 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 18417613 | ||
| Pubmed | 1.22e-05 | 14 | 114 | 3 | 30510198 | ||
| Pubmed | TRPM6 DMTF1 PRAMEF18 TRIM5 ORC4 PACS1 TAOK3 PAXBP1 CDK5RAP2 MACF1 PAN3 KIF13A DEDD MAN1B1 | 1.30e-05 | 1084 | 114 | 14 | 11544199 | |
| Pubmed | DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | 1.42e-05 | 238 | 114 | 7 | 35864588 | |
| Pubmed | 1.46e-05 | 437 | 114 | 9 | 20562859 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | KRT1 KRT2 EPPK1 DSP CEP290 ARFGEF2 PRAMEF18 VPS13D KRT76 MYO15A | 1.75e-05 | 564 | 114 | 10 | 21565611 |
| Pubmed | Hague (Hag). A new mouse hair mutation with an unstable semidominant allele. | 1.86e-05 | 16 | 114 | 3 | 12399393 | |
| Pubmed | 2.90e-05 | 266 | 114 | 7 | 19380743 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 19332778 | ||
| Pubmed | Specific functions of BIG1 and BIG2 in endomembrane organization. | 3.19e-05 | 3 | 114 | 2 | 20360857 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 16866877 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 18832381 | ||
| Pubmed | Involvement of BIG1 and BIG2 in regulating VEGF expression and angiogenesis. | 3.19e-05 | 3 | 114 | 2 | 31199673 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 26581228 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 18003980 | ||
| Pubmed | Enhancement of β-catenin activity by BIG1 plus BIG2 via Arf activation and cAMP signals. | 3.19e-05 | 3 | 114 | 2 | 27162341 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 23386609 | ||
| Pubmed | Characterization of cDNA clones in size-fractionated cDNA libraries from human brain. | 3.53e-05 | 56 | 114 | 4 | 9455484 | |
| Pubmed | 4.37e-05 | 21 | 114 | 3 | 22935613 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 5.65e-05 | 202 | 114 | 6 | 33005030 | |
| Pubmed | 6.35e-05 | 65 | 114 | 4 | 29795372 | ||
| Pubmed | TRIF mediates Toll-like receptor 2-dependent inflammatory responses to Borrelia burgdorferi. | 6.36e-05 | 4 | 114 | 2 | 23166161 | |
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 9261168 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 11013081 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 21339365 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 20357587 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 16923132 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 12606707 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 12571360 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 22084092 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 29932616 | ||
| Pubmed | A regulatory role for macrophage class A scavenger receptors in TLR4-mediated LPS responses. | 6.36e-05 | 4 | 114 | 2 | 20162551 | |
| Pubmed | Complete Structure of an Epithelial Keratin Dimer: Implications for Intermediate Filament Assembly. | 6.36e-05 | 4 | 114 | 2 | 26181054 | |
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 32179842 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 23296706 | ||
| Pubmed | 6.60e-05 | 24 | 114 | 3 | 27507811 | ||
| Pubmed | 6.75e-05 | 66 | 114 | 4 | 12221128 | ||
| Pubmed | KRT1 KRT2 KRT3 MYH2 MYH3 DSP SPEF2 MSL1 TEX14 KRT76 KRT75 SYNE2 MACF1 ATP11C PLXNA2 | 7.57e-05 | 1442 | 114 | 15 | 35575683 | |
| Pubmed | Proteomic characterization of the human centrosome by protein correlation profiling. | 8.44e-05 | 26 | 114 | 3 | 14654843 | |
| Pubmed | 9.47e-05 | 27 | 114 | 3 | 29374058 | ||
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 19880493 | ||
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 6196357 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 1.06e-04 | 5 | 114 | 2 | 3829126 | |
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 6879174 | ||
| Pubmed | KRT1 KRT2 KRT3 DSP POLRMT LCK KRT80 KRT76 KRT75 RABGAP1L BYSL MACF1 PSMD14 | 1.07e-04 | 1153 | 114 | 13 | 29845934 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | OFD1 DSP PRR5 LCK VPS13D SRGAP1 RABGAP1L SYNE2 MACF1 PAN3 KIF13A | 1.28e-04 | 861 | 114 | 11 | 36931259 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.32e-04 | 582 | 114 | 9 | 20467437 | |
| Pubmed | 1.58e-04 | 6 | 114 | 2 | 10444070 | ||
| Pubmed | 1.58e-04 | 6 | 114 | 2 | 1728586 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 1.58e-04 | 6 | 114 | 2 | 10077619 | |
| Pubmed | Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signaling. | 1.58e-04 | 6 | 114 | 2 | 10733577 | |
| Pubmed | Epiplakin attenuates experimental mouse liver injury by chaperoning keratin reorganization. | 1.58e-04 | 6 | 114 | 2 | 25617501 | |
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 1.58e-04 | 6 | 114 | 2 | 10588881 | |
| Pubmed | KRT2 OFD1 DSP CEP290 ME1 ITPR3 PACS1 VANGL1 SYNE2 CPSF1 CDK5RAP2 PSMD14 | 1.75e-04 | 1049 | 114 | 12 | 27880917 | |
| Pubmed | 1.84e-04 | 159 | 114 | 5 | 30581152 | ||
| Pubmed | 2.21e-04 | 7 | 114 | 2 | 35210422 | ||
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 2.21e-04 | 7 | 114 | 2 | 29758057 | |
| Pubmed | PKC epsilon is associated with myosin IIA and actin in fibroblasts. | 2.21e-04 | 7 | 114 | 2 | 11897493 | |
| Pubmed | 2.21e-04 | 7 | 114 | 2 | 16543150 | ||
| Pubmed | 2.21e-04 | 7 | 114 | 2 | 16819597 | ||
| Pubmed | A fine-tuning mechanism underlying self-control for autophagy: deSUMOylation of BECN1 by SENP3. | 2.21e-04 | 7 | 114 | 2 | 31373534 | |
| Pubmed | 2.28e-04 | 493 | 114 | 8 | 15368895 | ||
| Pubmed | TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity. | 2.35e-04 | 91 | 114 | 4 | 34445801 | |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 2.38e-04 | 168 | 114 | 5 | 30631154 | |
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | 2.38e-04 | 630 | 114 | 9 | 36949045 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT1 KRT2 KRT3 EPPK1 DSP SENP3 POLRMT TUBGCP2 KRT80 ITPR3 SRGAP1 BYSL CPSF1 | 2.49e-04 | 1257 | 114 | 13 | 36526897 |
| Pubmed | 2.94e-04 | 8 | 114 | 2 | 7543090 | ||
| Pubmed | 2.94e-04 | 8 | 114 | 2 | 20424327 | ||
| Pubmed | 2.94e-04 | 8 | 114 | 2 | 31537781 | ||
| Pubmed | In vivo analysis of Lrig genes reveals redundant and independent functions in the inner ear. | 2.94e-04 | 8 | 114 | 2 | 24086156 | |
| Pubmed | 2.94e-04 | 8 | 114 | 2 | 16565076 | ||
| Pubmed | Lymphotoxin β receptor activation on macrophages induces cross-tolerance to TLR4 and TLR9 ligands. | 2.94e-04 | 8 | 114 | 2 | 22357629 | |
| Pubmed | 3.09e-04 | 653 | 114 | 9 | 22586326 | ||
| Pubmed | 3.37e-04 | 100 | 114 | 4 | 21800051 | ||
| Pubmed | 3.39e-04 | 281 | 114 | 6 | 24163370 | ||
| Pubmed | 3.78e-04 | 9 | 114 | 2 | 27146717 | ||
| Pubmed | The P4-type ATPase ATP11C is essential for B lymphopoiesis in adult bone marrow. | 3.78e-04 | 9 | 114 | 2 | 21423172 | |
| Pubmed | 3.78e-04 | 9 | 114 | 2 | 23453969 | ||
| Pubmed | 4.01e-04 | 407 | 114 | 7 | 12693553 | ||
| Pubmed | 4.09e-04 | 189 | 114 | 5 | 31594818 | ||
| Pubmed | 4.71e-04 | 10 | 114 | 2 | 23576398 | ||
| Pubmed | 4.71e-04 | 10 | 114 | 2 | 1409609 | ||
| Pubmed | 4.71e-04 | 10 | 114 | 2 | 20488784 | ||
| Interaction | KRT25 interactions | 3.66e-08 | 35 | 112 | 6 | int:KRT25 | |
| Interaction | KRT32 interactions | 1.53e-07 | 44 | 112 | 6 | int:KRT32 | |
| Interaction | KRT28 interactions | 6.18e-07 | 30 | 112 | 5 | int:KRT28 | |
| Interaction | KRT33B interactions | 8.66e-07 | 93 | 112 | 7 | int:KRT33B | |
| Interaction | KRT40 interactions | KRT1 KRT2 KRT3 MYH2 MYH3 INPP5D TUBGCP2 CRY2 KRT76 KRT75 BYSL CDK5RAP2 ZNF844 | 8.81e-07 | 434 | 112 | 13 | int:KRT40 |
| Interaction | KRT39 interactions | 9.13e-07 | 59 | 112 | 6 | int:KRT39 | |
| Interaction | KRT8 interactions | KRT1 KRT2 KRT3 EPPK1 OFD1 DSP ARFGEF1 ITPR3 KRT76 KRT75 BYSL CDK5RAP2 DEDD | 1.05e-06 | 441 | 112 | 13 | int:KRT8 |
| Interaction | KRT14 interactions | 1.27e-06 | 192 | 112 | 9 | int:KRT14 | |
| Interaction | KRT37 interactions | 1.42e-06 | 100 | 112 | 7 | int:KRT37 | |
| Interaction | KRT36 interactions | 3.51e-06 | 74 | 112 | 6 | int:KRT36 | |
| Interaction | KRT18 interactions | KRT1 KRT2 KRT3 EPPK1 OFD1 DSP CEP290 ITPR3 KRT76 KRT75 CCDC42 DEDD | 3.78e-06 | 419 | 112 | 12 | int:KRT18 |
| Interaction | RNF208 interactions | 3.80e-06 | 75 | 112 | 6 | int:RNF208 | |
| Interaction | KRT19 interactions | 3.96e-06 | 282 | 112 | 10 | int:KRT19 | |
| Interaction | PHTF1 interactions | 4.09e-06 | 20 | 112 | 4 | int:PHTF1 | |
| Interaction | KRT38 interactions | 5.35e-06 | 172 | 112 | 8 | int:KRT38 | |
| Interaction | KRT12 interactions | 8.82e-06 | 24 | 112 | 4 | int:KRT12 | |
| Interaction | KRT24 interactions | 1.23e-05 | 54 | 112 | 5 | int:KRT24 | |
| Interaction | KRT16 interactions | 1.44e-05 | 197 | 112 | 8 | int:KRT16 | |
| Interaction | KRT20 interactions | 2.63e-05 | 63 | 112 | 5 | int:KRT20 | |
| Interaction | KRT35 interactions | 3.63e-05 | 111 | 112 | 6 | int:KRT35 | |
| Interaction | KRT26 interactions | 4.14e-05 | 35 | 112 | 4 | int:KRT26 | |
| Interaction | KRT13 interactions | 4.65e-05 | 116 | 112 | 6 | int:KRT13 | |
| Interaction | SDCBP2 interactions | 5.04e-05 | 72 | 112 | 5 | int:SDCBP2 | |
| Interaction | KRT7 interactions | 8.36e-05 | 80 | 112 | 5 | int:KRT7 | |
| Interaction | AHI1 interactions | 9.96e-05 | 83 | 112 | 5 | int:AHI1 | |
| Interaction | KRT5 interactions | 1.03e-04 | 193 | 112 | 7 | int:KRT5 | |
| Interaction | KRT84 interactions | 1.58e-04 | 49 | 112 | 4 | int:KRT84 | |
| Interaction | CASP10 interactions | 1.85e-04 | 51 | 112 | 4 | int:CASP10 | |
| Interaction | RP9 interactions | 2.29e-04 | 99 | 112 | 5 | int:RP9 | |
| Interaction | DES interactions | 2.55e-04 | 158 | 112 | 6 | int:DES | |
| Interaction | NME7 interactions | 2.73e-04 | 160 | 112 | 6 | int:NME7 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq26 | CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A8 CT45A3 CT45A5 | 5.18e-10 | 171 | 114 | 9 | chrXq26 |
| Cytoband | 12q13.13 | 7.38e-07 | 67 | 114 | 5 | 12q13.13 | |
| Cytoband | Xq26.3 | 7.38e-07 | 67 | 114 | 5 | Xq26.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 1.14e-05 | 423 | 114 | 8 | chr12q13 | |
| Cytoband | Xq27.1 | 8.11e-04 | 17 | 114 | 2 | Xq27.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 1.77e-03 | 346 | 114 | 5 | chr17p13 | |
| GeneFamily | Keratins, type II | 6.28e-10 | 27 | 68 | 6 | 609 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.81e-06 | 8 | 68 | 3 | 939 | |
| GeneFamily | Myosin heavy chains | 1.42e-03 | 15 | 68 | 2 | 1098 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_1_CELL | CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A8 CT45A3 CT45A5 | 1.70e-11 | 69 | 113 | 9 | M45681 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL | CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A8 CT45A3 CT45A5 PLXNA2 | 2.75e-11 | 104 | 113 | 10 | M45682 |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP | 2.56e-05 | 199 | 113 | 7 | M4526 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 7.49e-07 | 198 | 113 | 7 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.34e-06 | 150 | 113 | 6 | 9d5bbdca19da60e1a2121ef64ec8e1375a5dbf6d | |
| ToppCell | Control-PLT_4|World / Disease Group and Platelet Clusters | 2.72e-06 | 154 | 113 | 6 | a2a03c5e6759c45aeeedf1e68ecb5a0112ef9a20 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.05e-06 | 157 | 113 | 6 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.40e-06 | 160 | 113 | 6 | 5cd4fbbd2ce671a8377416eff94041a111375dee | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.82e-06 | 170 | 113 | 6 | fefb07a7e308b620f946b9ff2b01e1796446fe38 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.10e-06 | 190 | 113 | 6 | d24af6af3271e34afab744352afd28be8a7cc5c3 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.10e-06 | 190 | 113 | 6 | 71a00f63fdd4eb4cc6f190d37e7a0417cdaafacb | |
| ToppCell | COPD-Lymphoid-T|World / Disease state, Lineage and Cell class | 9.66e-06 | 192 | 113 | 6 | eb4909574fb5fc91399463523e2737095773200a | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 9.95e-06 | 193 | 113 | 6 | 2f203f6f0c2135acb046c9351a633c3b5b254a46 | |
| ToppCell | COPD-Lymphoid-T|COPD / Disease state, Lineage and Cell class | 1.09e-05 | 196 | 113 | 6 | 30e53b8050d2a041f855d0e39bbd8f923c64c489 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.12e-05 | 197 | 113 | 6 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | Thalamus|World / BrainAtlas - Mouse McCarroll V32 | 1.17e-05 | 116 | 113 | 5 | 5ddfb2dd5459ff6d7ae38163a38eae64fda283b7 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.45e-05 | 153 | 113 | 5 | b37a1ecad389d2848b8ca4d287823e8048207420 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Cpa6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.59e-05 | 154 | 113 | 5 | 12cbc38bc1f7231c67e1d2d5e86e95bc12e24682 | |
| ToppCell | Control-T_cells-Tregs|Control / group, cell type (main and fine annotations) | 7.13e-05 | 169 | 113 | 5 | e1e0983f31ec81b3fad5f9c6140d17f03f81a5dc | |
| ToppCell | IIF-Lymphocyte-T_NK-Treg|IIF / Disease, Lineage and Cell Type | 7.13e-05 | 169 | 113 | 5 | aac6ff89e0b3bc1f644e6cc6a696360659b254b5 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-05 | 172 | 113 | 5 | b440184f2d98d2f2d59566795f44fb79c0647ca4 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 8.87e-05 | 177 | 113 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-1|TCGA-Liver / Sample_Type by Project: Shred V9 | 9.10e-05 | 178 | 113 | 5 | 51c59dabf2d7aef1b1964f6f766d5ec07ef90f5a | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-05 | 179 | 113 | 5 | 88dbec952507d84b85b08165eec80df99ed1e736 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-05 | 179 | 113 | 5 | daf8189a22786171e2b629261cf720736aa4ebdb | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.85e-05 | 181 | 113 | 5 | 8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-04 | 182 | 113 | 5 | f30e5a21b49f30b82e2b6f1fd2daefd805a40083 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-MAIT|COVID-19_Severe / Disease group, lineage and cell class | 1.01e-04 | 182 | 113 | 5 | 19045db5c726c06ec6e4feb4311633c8164ddb3c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.01e-04 | 182 | 113 | 5 | cccac9f85825f4e310b86e37ee6320769a670501 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-04 | 182 | 113 | 5 | 1444cdc4522a70a40d697ccadf54cf26d327ade0 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.01e-04 | 182 | 113 | 5 | 49eced222e8f90c2b59bcc7d56b62c3e703fcce5 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.04e-04 | 183 | 113 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 183 | 113 | 5 | 6ca7c2d7c56e0f1b9038ba677b4c1c3dfd63bfce | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_memory_T_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.04e-04 | 183 | 113 | 5 | 4c566be2dbbac36936f065af57b524403aae9711 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 183 | 113 | 5 | 18040d0653286071df959513c63d94b555a5d00a | |
| ToppCell | Control-Lymphocyte-T_NK-CD4_TCM|Control / Disease, Lineage and Cell Type | 1.15e-04 | 187 | 113 | 5 | 1de80f40f753b31aed1fac9f3ff8a2ee6c755eec | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 1.15e-04 | 187 | 113 | 5 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-04 | 187 | 113 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Tregs|Lung / Manually curated celltypes from each tissue | 1.18e-04 | 188 | 113 | 5 | 604f340052807bd902915eca942a97ccc36b42e0 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-04 | 189 | 113 | 5 | fa1ff8b7fa53f3148d9117d6e598097f03af5eb2 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-04 | 189 | 113 | 5 | 565063f9e3dd79164321f8a394bd12c176baf202 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-04 | 189 | 113 | 5 | 497be236848ebf5ad75d1f0c71e6261f5d3521da | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-04 | 190 | 113 | 5 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | Control-Lymphoid-T|World / Disease state, Lineage and Cell class | 1.30e-04 | 192 | 113 | 5 | 253cf4d2cf88ad8c45b73779336180840bef054b | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-Tregs|lymph-node_spleen / Manually curated celltypes from each tissue | 1.30e-04 | 192 | 113 | 5 | 91a4d06e8d1d1fe2ce5f72668108513bd2a72c4d | |
| ToppCell | IPF-Lymphoid-T|World / Disease state, Lineage and Cell class | 1.30e-04 | 192 | 113 | 5 | b25ba1f3bc842c22602b2aeed3b1b5082863e4fa | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.33e-04 | 193 | 113 | 5 | 9c9434a3297b85774b4f0ecab6294f44d738e29f | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 194 | 113 | 5 | a3adcdc8b87332e8beb9bcd70cf36424af10633d | |
| ToppCell | COVID-19-lung-NK_cells|lung / Disease (COVID-19 only), tissue and cell type | 1.40e-04 | 195 | 113 | 5 | 3b716ec7acc9a37af6bf40e711a539ce58d74aa4 | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.40e-04 | 195 | 113 | 5 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-T4_em-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.40e-04 | 195 | 113 | 5 | 48905d57775ec90cc031af0863cc8c3800f2e48e | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 1.43e-04 | 196 | 113 | 5 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.43e-04 | 196 | 113 | 5 | 03de28e1c963e99623e8b0e33bf2e8ef67dc3baa | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.43e-04 | 196 | 113 | 5 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.46e-04 | 197 | 113 | 5 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-04 | 197 | 113 | 5 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.46e-04 | 197 | 113 | 5 | e621d4f9d4ba5e3ef17d2b477e5e14ea0251147e | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.46e-04 | 197 | 113 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.50e-04 | 198 | 113 | 5 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | severe-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.50e-04 | 198 | 113 | 5 | 4935b40fc848037a06055f30d90bde940b9d5321 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.53e-04 | 199 | 113 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Skin|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.53e-04 | 199 | 113 | 5 | 6be1340413ee868c610b6e3f58c65b493eb22bb5 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.53e-04 | 199 | 113 | 5 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.53e-04 | 199 | 113 | 5 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.53e-04 | 199 | 113 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Kidney-Keratinocytes|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.57e-04 | 200 | 113 | 5 | 41d83faa9f45ee7ea2ab19be8ecc6d2c5ac7fe5d | |
| ToppCell | Biopsy_Other_PF-Epithelial-KRT5-/KRT17+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.57e-04 | 200 | 113 | 5 | 077e6b9340686de9d0f11b035a8954e1f6a1b790 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-MAIT|COVID-19_Severe / Disease, condition lineage and cell class | 1.57e-04 | 200 | 113 | 5 | b8cfccecff9900aee323c40e771c94e560b8c488 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-CD4+_Tem|URO / Disease, condition lineage and cell class | 1.57e-04 | 200 | 113 | 5 | 8b7bfe6411de9528603481f6e5612cbbb8471cf6 | |
| ToppCell | severe-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.57e-04 | 200 | 113 | 5 | 8a849d0ef244aa2666da2d31bd0731fb04e40911 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-CD8+_Tcm|Int-URO / Disease, condition lineage and cell class | 1.57e-04 | 200 | 113 | 5 | 9535fd16a962d57e80319bc26093617e04c8b2a8 | |
| ToppCell | Skin-Keratinocytes|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.57e-04 | 200 | 113 | 5 | 59d72395199bc30df0e811fbc99149694e208860 | |
| ToppCell | severe-MAIT|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.57e-04 | 200 | 113 | 5 | 1daf43f1bdd49585dce5e957820554d7f3c1bd4a | |
| ToppCell | mild-CD4+_Tcm|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.57e-04 | 200 | 113 | 5 | dc10628886d1d3ff9dce25ade10920e69a6ab8c2 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-CD4+_Tcm|URO / Disease, condition lineage and cell class | 1.57e-04 | 200 | 113 | 5 | 4689fd4c6e7f078d7e91783a1646dd85c03cba77 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-CD8+_Tcm|Multiple_Sclerosis / Disease, condition lineage and cell class | 1.57e-04 | 200 | 113 | 5 | d9d888842d84a2b70173896d81ca183fa53c814c | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-MAIT|Int-URO / Disease, condition lineage and cell class | 1.57e-04 | 200 | 113 | 5 | 043c18e79a969e37bbff86443e553ac09fe33f84 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Papillary-5|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.84e-04 | 111 | 113 | 4 | eb737146969b70c619649f244998d4183237c763 | |
| Drug | Amidopyrine [58-15-1]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 4.58e-06 | 197 | 108 | 8 | 2222_DN | |
| Drug | Midecamycin [35457-80-8]; Down 200; 5uM; MCF7; HT_HG-U133A | 4.75e-06 | 198 | 108 | 8 | 5345_DN | |
| Disease | cinnamaldehyde measurement | 1.14e-05 | 2 | 100 | 2 | EFO_0021839 | |
| Disease | Striate palmoplantar keratoderma | 3.40e-05 | 3 | 100 | 2 | C4707237 | |
| Disease | Kartagener Syndrome | 2.28e-04 | 35 | 100 | 3 | C0022521 | |
| Disease | Polynesian Bronchiectasis | 2.28e-04 | 35 | 100 | 3 | C4317124 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 2.28e-04 | 35 | 100 | 3 | C4551906 | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 5.03e-04 | 10 | 100 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 5.03e-04 | 10 | 100 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 5.03e-04 | 10 | 100 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 5.03e-04 | 10 | 100 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 5.03e-04 | 10 | 100 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 5.03e-04 | 10 | 100 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 5.03e-04 | 10 | 100 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 5.03e-04 | 10 | 100 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | Primary Ciliary Dyskinesia | 5.50e-04 | 47 | 100 | 3 | C4551720 | |
| Disease | distal myopathy (implicated_via_orthology) | 7.34e-04 | 12 | 100 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 7.34e-04 | 12 | 100 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 8.66e-04 | 13 | 100 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.16e-03 | 15 | 100 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | cortical thickness | PALD1 NPR2 NBEAL1 ARFGEF2 ME1 VPS13D CDK5RAP2 MACF1 KIF13A PLXNA2 SMG6 | 1.38e-03 | 1113 | 100 | 11 | EFO_0004840 |
| Disease | Familial aplasia of the vermis | 2.08e-03 | 20 | 100 | 2 | cv:C0431399 | |
| Disease | colorectal carcinoma (is_implicated_in) | 2.51e-03 | 22 | 100 | 2 | DOID:0080199 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MARALQKYLRITRQQ | 401 | Q8TAA9 | |
| MDDLLNKTRYNNLIR | 31 | P30926 | |
| TKMRNVIYQNRLALD | 541 | Q14264 | |
| KMAQLRAELLQLYER | 611 | Q86US8 | |
| IRVLLGKMNRLLNYA | 651 | Q5W0A0 | |
| LQQGLERLYEMILKR | 176 | P49703 | |
| SMQTKLNYLRRNLLI | 36 | Q5JRM2 | |
| KRKERLQMLQTNYRA | 561 | Q9NXG0 | |
| KLRRIQSNYMALQRI | 56 | Q9BUH8 | |
| VASEKQRRLLYNLEM | 901 | Q9Y6D6 | |
| VASEKQRRLLYNLEM | 846 | Q9Y6D5 | |
| SYQKRQRMALLARKQ | 26 | P0DMU8 | |
| SNDLLLIRKNRMALF | 441 | Q13489 | |
| QMARLQQLYLQLRIQ | 201 | Q8NAV2 | |
| LLLRMEQYANNLEKL | 801 | P20594 | |
| YELGRQKLLRNLMLQ | 301 | O75618 | |
| RLQYGERLLQMLQKL | 16 | Q96M95 | |
| IDILMNNIERYLKAR | 161 | Q9Y222 | |
| SYQKRQRMALLARKQ | 26 | P0DMV0 | |
| QGRLRALFMKQIYLQ | 176 | Q86XH1 | |
| NLKLRIYFLEERMQQ | 76 | Q96SN8 | |
| LANVENYSRMRLKLV | 1801 | Q6ZS30 | |
| EIYAQRQLLLKDMDL | 281 | O75665 | |
| DRGNQLRKMLLQNYL | 1681 | Q14573 | |
| LRKMLLQNYLQNRKS | 1686 | Q14573 | |
| AQEMRRLQLRSLQYL | 761 | Q9ULE6 | |
| LARLLRDYQELMNVK | 461 | Q01546 | |
| QREYQLMKLLLDNTQ | 396 | O43929 | |
| RYLLLMDLQDRNEKL | 71 | P48163 | |
| LRRQQIKISMENDYL | 396 | Q8N9B5 | |
| RLANYLQKVRMLERE | 106 | Q6A163 | |
| KLILRYLAAMNQKRE | 1326 | Q9UKN7 | |
| SYQKRQRMALLARKQ | 26 | P0DMU9 | |
| LARLLRDYQELMNVK | 456 | P35908 | |
| LLRDYQELMNVKLAL | 481 | P12035 | |
| RQLRKYQELMNVKLA | 361 | Q6KB66 | |
| MQEKTYRRLLMLQNA | 1351 | Q10570 | |
| YRRLLMLQNALTTML | 1356 | Q10570 | |
| RQRLAYKVEQLINAM | 1876 | O75051 | |
| LLRDYQELMNTKLAL | 461 | P04264 | |
| LFRENLNKLMTNLRS | 656 | Q9UKX2 | |
| SYQKRQRMALLARKQ | 26 | Q8NHU0 | |
| SVLLRLENLQMLYVR | 261 | Q5VWM3 | |
| YNQLLDKGRLMLLSR | 2516 | O94854 | |
| KQYLQRQERLRLKQM | 261 | Q969V5 | |
| QEMIRQLEQTNYRLK | 176 | Q99836 | |
| LMKQLQHQRLVRLYA | 291 | P06239 | |
| LSLIINRKALTRYQM | 626 | Q9BSJ2 | |
| NKNTQVYLKALLLRM | 726 | Q9Y5B6 | |
| REQRILQRLQLRMYK | 526 | Q68DK7 | |
| REKLLLMYQTNDQII | 1231 | Q8IVE3 | |
| KQLSRLQRNMILFLL | 76 | Q9UKM7 | |
| DANKLQIMLQRRKRY | 186 | Q6VY07 | |
| DNQAMLDRYRILITK | 556 | Q5R372 | |
| KNLILYLLTDQNRMR | 726 | Q58A45 | |
| ISRFLLYMKNLLNRI | 356 | Q8TAX7 | |
| QLREYQDLLNVKMAL | 381 | P12036 | |
| SYQKRQRMALLARKQ | 26 | Q5HYN5 | |
| SYQKRQRMALLARKQ | 26 | P0DMV2 | |
| TQLLKRTQAMLNKYR | 761 | Q6AI39 | |
| LYLLKQELQRANMVS | 226 | Q9BXL6 | |
| LCMENRYLQERLKQL | 161 | Q6ZUS6 | |
| SRLNIERMKQIYQQL | 496 | Q49AN0 | |
| YRDILQKDNMLVQRT | 976 | O15078 | |
| MQNTKLLFRTLRNNL | 281 | A2CJ06 | |
| SYQKRQRMALLARKQ | 26 | Q5DJT8 | |
| RLLQLQEQMRALYKA | 141 | P15924 | |
| LLSQNELYRQILLLM | 581 | Q6NUI2 | |
| RQMFLLQYALDVKRR | 156 | Q494V2 | |
| QVLNLQARLRVLEMY | 66 | Q9UEW3 | |
| YINKEKRLQLSRMLN | 256 | O43248 | |
| SYQKRQRMALLARKQ | 26 | P0DMV1 | |
| AIRLNNKMPLLYLNR | 316 | Q8WXU2 | |
| MREKLIRLQSLYIDQ | 196 | Q9H9L4 | |
| KRTQAMLNKYRLLLL | 1146 | Q9NZM4 | |
| LRRQQIRTKNLLPMY | 541 | Q92622 | |
| GQRQKRKLLTLDMYN | 251 | O00411 | |
| LKERMAQRFYNLVLL | 241 | Q13895 | |
| SYQKRQRMALLARKQ | 26 | P0DMU7 | |
| NYRKNELEQKMLLNL | 206 | O00487 | |
| MELVLRKRIAANIYN | 1266 | Q9H1H9 | |
| RRRSMNEIKNLQYLP | 551 | Q5VWQ0 | |
| SLRNLMADYLRQIIQ | 1176 | Q8N1G1 | |
| LDLRSFQMQYNLRLR | 176 | Q6PI48 | |
| QYLNRRRQNEIMAKI | 196 | Q9C093 | |
| MLRYQQLQSRLATLK | 356 | Q7Z6B7 | |
| QKDRTMNLQDIRYIL | 496 | Q8IWB6 | |
| QLRAQILAYKMLARG | 181 | P51531 | |
| LRNQYQMLVLKSTQR | 2811 | Q8WXH0 | |
| YLQNQLLTKGMVILR | 86 | P85299 | |
| GQRLSLYQAMRQKLL | 941 | P58107 | |
| SEKKLRRNQNYMNIL | 546 | Q92835 | |
| LYEKLLVQRLNMGTQ | 486 | Q96JF0 | |
| YRQLHTLQKLRMDLI | 661 | Q9H2K8 | |
| LFRENLNKLMSNLRT | 651 | P11055 | |
| RNLLYRLQLGMLQQA | 351 | P78539 | |
| EMLYILDQRLRAQNI | 16 | Q8WVF1 | |
| YERINRQLIEAKMAL | 611 | Q8NB49 | |
| RKGLVLQLIQSYQRM | 356 | Q9H4L4 | |
| REYQVKLQAALEMLR | 136 | Q9C035 | |
| KSLYRNVMQETIRNL | 26 | P16415 | |
| NEMKLRRNLEKYLSL | 261 | Q9BX84 | |
| SEYMRLRQLKRLQAN | 21 | Q92800 | |
| KNLYREVMQETLRNL | 26 | Q08AG5 | |
| LLDDAQRLLYRNVML | 31 | Q6PK81 | |
| KLYREVMLENFRNLL | 31 | Q9UK10 | |
| KNLYREVMQETLRNL | 46 | Q6ZQV5 | |
| LQRVRELEDMYLKLQ | 416 | Q9UH65 | |
| CQMLYNRRKILQLKR | 2256 | Q9BXT5 | |
| RLSLEQRNLYKEVML | 51 | Q86UQ0 | |
| NVLRYIQLTQLKMNR | 206 | Q8N6N2 | |
| ILMRVLRNDLARYNL | 256 | O15321 | |
| KNLYREVMQETLRNL | 26 | C9JN71 | |
| LKLSQLQYRQIMEFL | 276 | Q5THJ4 | |
| LREYQELMNIKLALD | 431 | O95678 | |
| RMQLKYLNLSNNRIT | 166 | O94898 |